The Neuro Stim System: Non-Narcotic Alternative for Acute and Chronic Pain, Opioid Reduction, and Sleep Enhancement

Christopher R. Brown DDS, MPS

The clinical application and efficacy of percutaneous electrical neural stimulation has been accepted throughout the physician community¹, has been verified for use in many acute and chronic pain conditions² and also been reported as an analgesic complementary therapy for the management of pain secondary to bony metastasis³. Percutaneous electrical neural stimulation is an entity unto itself and is clearly distinguished from manual acupuncture, electrical acupuncture and/ or TENS⁴⁵. NSS neurostimulation therapy is distinguished as a neurological entity within the subset of PENS.

1. Anthem Clinical UM Guidelines, Electrical Nerve Stimulation, Transcutaneous, Percutaneous.Guideline # CG-DME-04, Status: revised. Current effective date: 10/12/2011. Last review date: 8/18/2011. 2. Blue Cross of Idaho. MP 7.01.29. Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT). Medical Policy. Section Surgery issue 8/20/11 Original Policy date 11/30/96. Last literature search 8/20/11 3. Ahmed, Hersham M.D., Craig, William M.D., et al. Percutaneous Electrical Nerve Stimulation (PENS): A Complementary Therapy for the Management of Pain Secondary to Bony Metastasis. Clinical Journal of Pain. Dec 1998, vol 14 issue 4, pp 320-323 4. Blue Cross/ Blue Shield Protocol. Percutaneous Electrical Nerve Stimulation (PENS) or Percutaneous Neuromodulation Therapy (PNT) (70129) effective October 1, 2009. Literature review May 2010. 5. University of Birmingham ARIF (Aggressive Research Intelligence Facility). ARIF Request. Percutaneous Electrical Stimulation (PENS) Chronic Pain (Breast and Back) Pain. Jan 2007.